BELANOFF JOSEPH K (Chief Executive Officer) sold 1.4% of their position (40K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $2.00M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/5/2026ACC: 0001193125-26-206540
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-40K
Net shares
Net seller
$2.00M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
40K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−40K
Price / share
$50.10
Trade value
$2M
% of position
1.4%
5/1/2026
2.92M→2.88M
Total
Net shares
−40K
Net value
-$2M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/1/2026 | S · Sale | −40K | $50.10 | $2M | 1.4% | 2.92M | 2.88M |
| Total | −40K | -$2M | ||||||
Derivative Transactions0
No derivative transactions reported